Clinical Efectivity of Two Different Sensor-augmented Pumps With Low Predictive Suspension Function

NCT04741685 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2021-06-11

No results posted yet for this study

Summary

Observational cross-sectional multicenter study about effectiveness of two different sensor augmented-pumps with low glucose predictive function in Type 1 Diabetes Mellitus (T1DM) adult patients in routine clinical practice.

Conditions

Interventions

DEVICE

TTSX2

Treatment with Tandem T Slim X2 with Basal IQ

DEVICE

MM640G

Treatment with Medtronic Minimed 640G with Smartguard

Sponsors & Collaborators

  • Castilla-La Mancha Health Service

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2021-06-01
Completion
2021-06-10
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04741685 on ClinicalTrials.gov